219 related articles for article (PubMed ID: 11848471)
1. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
3. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression.
Thompson MA; Rosenthal MA; Ellis SL; Friend AJ; Zorbas MI; Whitehead RH; Ramsay RG
Cancer Res; 1998 Nov; 58(22):5168-75. PubMed ID: 9823328
[TBL] [Abstract][Full Text] [Related]
4. Detection of C-myb genetic alterations and mutant p53 serum protein in patients with benign and malignant colon lesions.
Greco C; Gandolfo GM; Mattei F; Gradilone A; Alvino S; Pastore LI; Casale V; Casole P; Grassi A; Cianciulli AM
Anticancer Res; 1994; 14(3B):1433-40. PubMed ID: 8067719
[TBL] [Abstract][Full Text] [Related]
5. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
6. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
7. The role of bcl-2 in the progression of the colorectal adenoma-carcinoma sequence.
Yang HB; Chow NH; Sheu BS; Chan SH; Chien CH; Su IJ
Anticancer Res; 1999; 19(1B):727-30. PubMed ID: 10216484
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of apoptosis during development of colorectal cancer.
Bedi A; Pasricha PJ; Akhtar AJ; Barber JP; Bedi GC; Giardiello FM; Zehnbauer BA; Hamilton SR; Jones RJ
Cancer Res; 1995 May; 55(9):1811-6. PubMed ID: 7728743
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.
Flohil CC; Janssen PA; Bosman FT
J Pathol; 1996 Apr; 178(4):393-7. PubMed ID: 8691316
[TBL] [Abstract][Full Text] [Related]
11. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression.
Sumitani K; Kamijo R; Nagumo M
Anticancer Res; 1997; 17(2A):865-71. PubMed ID: 9137419
[TBL] [Abstract][Full Text] [Related]
13. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG
Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
Donzelli M; Bernardi R; Negri C; Prosperi E; Padovan L; Lavialle C; Brison O; Scovassi AI
Oncogene; 1999 Jan; 18(2):439-48. PubMed ID: 9927200
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression.
Antalis TM; Reeder JA; Gotley DC; Byeon MK; Walsh MD; Henderson KW; Papas TS; Schweinfest CW
Clin Cancer Res; 1998 Aug; 4(8):1857-63. PubMed ID: 9717812
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study on the progression of colorectal cancer--with respect to apoptotic index, expression of apoptosis-related gene products, and labeling index of proliferating cell nuclear antigen (PCNA)].
Watanabe I; Isozaki H; Toyoda M; Ishibashi T; Hara H; Niki M; Gon G; Tenjo T; Kawasaki H; Tanigawa N
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():410-4. PubMed ID: 9589044
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].
Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785
[TBL] [Abstract][Full Text] [Related]
19. Changes of angiogenesis and tumor cell apoptosis during colorectal carcinogenesis.
Aotake T; Lu CD; Chiba Y; Muraoka R; Tanigawa N
Clin Cancer Res; 1999 Jan; 5(1):135-42. PubMed ID: 9918211
[TBL] [Abstract][Full Text] [Related]
20. Dysfunction of the Myc-induced apoptosis mechanism accompanies c-myc activation in the tumorigenic L929 cell line.
Facchini LM; Chen S; Penn LJ
Cell Growth Differ; 1994 Jun; 5(6):637-46. PubMed ID: 8086339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
